“COST-EFFECTIVENESS OF BEVACIZUMAB AND RANIBIZUMAB AS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR PATIENTS WITH EYE DISORDERS: A SYSTEMATIC REVIEW”. Kartika Jurnal Ilmiah Farmasi, vol. 9, no. 1, Apr. 2024, pp. 37-53, https://doi.org/10.26874/kjif.v9i1.658.